Isometric diagram of a glowing peptide ribbon linked to two distinct cell-surface receptors in a membrane, representing a dual GIP/GLP-1 agonist
Mindful Research

Tirzepatide: A Dual GIP/GLP-1 Receptor Agonist in In-Vitro Research

Updated By: Mindful Research Team2 min read

Key takeaways

  • Tirzepatide is studied in vitro as a dual agonist of the GIP and GLP-1 incretin receptors.
  • It engages two G-protein-coupled receptors, unlike single-agonist reference compounds.
  • It is characterized by receptor-binding and cell-based signaling assays (e.g. cyclic AMP) for each receptor.
  • It is listed in the catalog as T-GLP2 (CAS 2023788-19-2), a naming convention, not the GLP-2 hormone.
  • Supplied as a research material for in vitro research use only.

Tirzepatide is a research peptide studied in vitro as a dual agonist of two incretin receptors: the GIP receptor and the GLP-1 receptor. This profile describes its targets and the laboratory assays used to characterize it.

What is tirzepatide?

Tirzepatide is a synthetic peptide used as a reference compound in incretin-receptor research. It is described here only by structure and molecular target, as a laboratory material. In supplier catalogs it is listed as T-GLP2 (CAS 2023788-19-2), a catalog naming convention parallel to RT-GLP3 for retatrutide; the label does not refer to the GLP-2 hormone.

What does it target in vitro?

Its distinguishing feature is dual activity: it engages both the GIP receptor and the GLP-1 receptor, two G-protein-coupled receptors in the incretin family. Single-agonist reference compounds engage only one of these.

How is it characterized in the lab?

Researchers use receptor-binding assays and cell-based signaling assays (for example, measuring cyclic AMP, a downstream messenger) in cells expressing each receptor. Running both receptors side by side quantifies the dual-agonist profile.

Why a dual agonist is studied

A compound that engages two related receptors is a useful tool for comparing receptor pathways in parallel under identical in-vitro conditions.

Related research guides

Research-use note

Tirzepatide is supplied as a research material for in vitro research use only. It is not for human or animal use.

Related research: RT-GLP3.

Frequently asked questions

What is tirzepatide in research terms?

A synthetic peptide used as a reference compound studied in vitro as a dual agonist of the GIP and GLP-1 receptors.

What makes it a dual agonist?

It engages both the GIP receptor and the GLP-1 receptor, two incretin-family G-protein-coupled receptors, rather than just one.

How is it studied in the lab?

With receptor-binding assays and cell-based signaling assays (such as cyclic AMP) in cells expressing each receptor. View T-GLP2 (tirzepatide)

What is T-GLP2?

T-GLP2 (also written GLP-2, GLP2, GLP-2 T or GLP 2T) is the catalog name for tirzepatide, CAS 2023788-19-2. It is a naming convention, not the GLP-2 hormone or a GLP-2 receptor analog. Sourcing T-GLP2 (tirzepatide)

Is it research use only?

Yes. It is supplied for in vitro laboratory research use only.

Continue reading

Vial of blue copper-complex lyophilized peptide powder in a cold-storage block, representing KLOW 80 mg handling and stabilityKLOW 80 mg: Copper-Complex Blue Lyophilized Powder, Handling, Stability and Stock Concentration Math The KLOW 80 mg vial is a pale-blue lyophilized powder because one of its four components, GHK-Cu, is a copper(II) complex; reconstituted... Researcher in a lab coat checking a vial of blue peptide blend powder against a four-peak analytical readoutSourcing KLOW as a Research Material: Per-Component COA and Purity Sourcing KLOW as a research material means obtaining, in one Certificate of Analysis, the identity and purity data for all four of... Two vials of blue peptide blend powder side by side, one with an extra tripeptide render, representing GLOW versus KLOWGLOW vs KLOW: What KPV Adds to the Blend (Composition Comparison) The difference between GLOW and KLOW is one component: KLOW adds 10 mg of the tripeptide KPV (Lys-Pro-Val, CAS 67727-97-3) to GLOW's...